BBNX - Beta Bionics, Inc.
9.71
-0.730 -7.518%
Share volume: 407,146
Last Updated: 04-08-2025
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies:
-0.03%
PREVIOUS CLOSE
CHG
CHG%
$10.44
-0.73
-0.07%
Fundamental analysis
4%
Profitability
0%
Dept financing
0%
Liquidity
0%
Performance
10%
Performance
5 Days
-2.02%
1 Month
-35.22%
3 Months
-58.91%
6 Months
-58.91%
1 Year
-58.91%
2 Year
-58.91%
Key data
Stock price
$9.71
DAY RANGE
$9.54 - $11.14
52 WEEK RANGE
$8.89 - $24.50
52 WEEK CHANGE
-$58.91
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-06-2025
Company detail
CEO: Sean Saint
Region: US
Website: www.betabionics.com
Employees: 294
IPO year: 2025
Issue type:
Market: NASDAQ
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing
Region: US
Website: www.betabionics.com
Employees: 294
IPO year: 2025
Issue type:
Market: NASDAQ
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing
We are a commercial-stage medical device company engaged in the design, development and commercialization of innovative solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing advanced adaptive closed-loop algorithms to simplify and improve the treatment of their disease. Our principal executive offices are located at 11 Hughes, Irvine, California.
Recent news
